Preparation method of fluorine-containing pyrimidine compound
A compound and pyrimidine technology, applied in the fields of materials and pharmaceutical intermediates synthesis, and natural products, can solve the problems of harsh reaction conditions, long reaction time, dangerous operation, etc., and achieve the effects of wide substrate range, high reaction efficiency and low cost.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] Example 1 Ethyl-2-amino-4-methyl-6-perfluoropropylpyrimidine-5-carboxylate
[0038] 1. Put guanidine hydrochloride and sodium hydroxide into a 25mL round-bottomed flask, inject 3mL of acetonitrile solvent, pre-treat and remove acid to obtain free guanidine. Then, ethyl acetoacetate and perfluoroiodobutane were added successively at room temperature. The reaction was carried out under room light and room temperature for 6 h, and the end point of the reaction was monitored by TLC, and the reaction was stopped to obtain a mixture.
[0039] In molar ratio, ethyl acetoacetate: perfluoroiodobutane: guanidine hydrochloride: sodium hydroxide=1.0:1.1:1.1:4.1;
[0040] 2. The mixture was extracted 3 times with water, the organic phases were combined, and the organic solvent was distilled off under reduced pressure to obtain a crude product;
[0041] 3. Pass the crude product through silica gel column chromatography, and elute with an eluent (petroleum ether: ethyl acetate = 30:...
Embodiment 2
[0047] Example 2 Methyl-2-amino-4-ethyl-6-perfluoropropylpyrimidine-5-carboxylate
[0048] 1. Put guanidine hydrochloride and sodium hydroxide into a 25mL round-bottomed flask, inject 3mL of acetonitrile solvent, pre-treat and remove acid to obtain free guanidine. Then, methyl 3-oxopentanoate and perfluoroiodobutane were added successively at room temperature. The reaction was carried out under room light and room temperature for 7 hours, the end point of the reaction was monitored by TLC, and the reaction was stopped to obtain a mixture.
[0049] In molar ratio, methyl 3-oxopentanoate: perfluoroiodobutane: guanidine hydrochloride: sodium hydroxide=1.0:1.1:1.1:4.1;
[0050] The mixture was extracted 3 times with water, the organic phases were combined, and the organic solvent was distilled off under reduced pressure to obtain a crude product;
[0051]2. The crude product is eluted by silica gel column chromatography with an eluent (petroleum ether: ethyl acetate = 30:1 (v:v)...
Embodiment 3
[0057] Example 3 Ethyl-2-amino-4-perfluoropropyl-6-phenylpyrimidine-5-carboxylate
[0058] 1. Put guanidine hydrochloride and sodium hydroxide into a 25mL round-bottomed flask, inject 3mL of acetonitrile solvent, pre-treat and remove acid to obtain free guanidine. Then, ethyl benzoylacetate and perfluoroiodobutane were added sequentially at room temperature. The reaction was carried out under room light and room temperature for 5 h, the end point of the reaction was monitored by TLC, and the reaction was stopped to obtain a mixture.
[0059] In molar ratio, ethyl benzoyl acetate: perfluoroiodobutane: guanidine hydrochloride: sodium hydroxide=1.0:1.1:1.1:4.1;
[0060] 2. The mixture was extracted 3 times with water, the organic phases were combined, and the organic solvent was distilled off under reduced pressure to obtain a crude product;
[0061] 3. Pass the crude product through silica gel column chromatography, and elute with an eluent (petroleum ether: ethyl acetate = 30...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


